4.5 Article

Differential Regulation of Tau Exon 2 and 10 Isoforms in Huntington's Disease Brain

Related references

Note: Only part of the references are listed.
Article Clinical Neurology

Dysregulated coordination of MAPT exon 2 and exon 10 splicing underlies different tau pathologies in PSP and AD

Kathryn R. Bowles et al.

Summary: Understanding the regulation of MAPT splicing is crucial for unraveling the pathogenesis of tauopathies, such as AD and PSP, where different tau isoforms accumulate. The study revealed the importance of N-terminal splicing and its coordination with exon 10 inclusion/exclusion in tauopathies.

ACTA NEUROPATHOLOGICA (2022)

Article Neurosciences

Widespread alterations in microRNA biogenesis in human Huntington's disease putamen

Serena Petry et al.

Summary: Mutant Huntingtin protein binds to Ago2 and disrupts mature miRNA levels. Ago2, Drosha, and Dicer were downregulated in early stages of Huntington's disease. Various types of maturation defects were observed in the HD brain, with the most prominent occurring at the pre-miRNA to mature miRNA step. These findings provide important clues into the underlying mechanisms behind miRNA alterations in HD-susceptible tissues.

ACTA NEUROPATHOLOGICA COMMUNICATIONS (2022)

Review Neurosciences

D1R-and D2R-Medium-Sized Spiny Neurons Diversity: Insights Into Striatal Vulnerability to Huntington's Disease Mutation

Guendalina Bergonzoni et al.

Summary: Huntington's disease is a devastating neurodegenerative disorder caused by an aberrant expansion of the CAG tract within the HTT gene. Despite the ubiquity of the HTT gene, striatal Medium-sized Spiny Neurons are particularly vulnerable to the HD mutation, with D1R and D2R displaying different susceptibility. Understanding cell type-specific gene expression dysregulation in the striatum may offer new paths for therapeutic intervention in HD patients.

FRONTIERS IN CELLULAR NEUROSCIENCE (2021)

Review Neurosciences

Human Tau Isoforms and Proteolysis for Production of Toxic Tau Fragments in Neurodegeneration

Ben Boyarko et al.

Summary: The human tau protein plays a crucial role in various neurodegenerative tauopathies, with alternative splicing and protease-mediated truncation being important mechanisms of tauopathies. Understanding the relationships between tau isoforms and their proteolytic processing is essential in developing new targeted drug strategies to prevent the formation of toxic tau fragments in neurodegenerative diseases.

FRONTIERS IN NEUROSCIENCE (2021)

Review Biochemistry & Molecular Biology

Non-Canonical Roles of Tau and Their Contribution to Synaptic Dysfunction

Giacomo Siano et al.

Summary: Tau plays a central role in tauopathies by causing neurodegeneration through misfolding and aggregation of Tau protein, leading to synaptic dysfunction. Research has shown that Tau undergoes post-translational modifications at the onset of pathology, resulting in detachment from the cytoskeleton, aggregation into toxic oligomers, and disruption of synaptic homeostasis, ultimately leading to neuronal degeneration.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Article Neurosciences

Differential Effects of the Six Human TAU Isoforms: Somatic Retention of 2N-TAU and Increased Microtubule Number Induced by 4R-TAU

Sarah Bachmann et al.

Summary: Different isoforms of the microtubule-associated protein TAU are expressed in the adult human brain, with specific isoforms accumulating in certain tauopathies. Our study found that 2N-TAU isoforms are particularly retained in axonal sorting, and that the additional repeat domain of 4R-TAU isoforms results in a general reduction of cell size and an increase of microtubule counts. These findings suggest that individual TAU isoforms may influence microtubule dynamics differently in cells.

FRONTIERS IN NEUROSCIENCE (2021)

Review Cell Biology

Altered microRNA expression in animal models of Huntington's disease and potential therapeutic strategies

Bridget Martinez et al.

Summary: Studies have shown that regulation of certain microRNAs in animal models and cell studies can improve symptoms of Huntington's disease, increase survival rates, and inhibit the production of mutant huntingtin protein.

NEURAL REGENERATION RESEARCH (2021)

Review Cell Biology

The regulatory roles of microRNAs toward pathogenesis and treatments in Huntington's disease

Chih-Wei Tung et al.

Summary: Huntington's disease is a monogenetic disease caused by mutation of the Huntingtin gene, while microRNA shows potential for regulating multiple pathways and providing therapy for inherited diseases like HD.

JOURNAL OF BIOMEDICAL SCIENCE (2021)

Review Neurosciences

Altered Levels and Isoforms of Tau and Nuclear Membrane Invaginations in Huntington's Disease

Marta Fernandez-Nogales et al.

FRONTIERS IN CELLULAR NEUROSCIENCE (2020)

Article Biochemistry & Molecular Biology

Asparagine residue 368 is involved in Alzheimer's disease tau strain-specific aggregation

Shotaro Shimonaka et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2020)

Review Clinical Neurology

Astrocytes in Tauopathies

Matthew J. Reid et al.

FRONTIERS IN NEUROLOGY (2020)

Review Medicine, Research & Experimental

Microtubules: Evolving roles and critical cellular interactions

Caitlin M. Logan et al.

EXPERIMENTAL BIOLOGY AND MEDICINE (2019)

Article Clinical Neurology

Co-occurrence of mixed proteinopathies in late-stage Huntington's disease

Isabelle St-Amour et al.

ACTA NEUROPATHOLOGICA (2018)

Review Biochemistry & Molecular Biology

Tau mis-splicing in the pathogenesis of neurodegenerative disorders

Sun Ah Park et al.

BMB REPORTS (2016)

Article Clinical Neurology

Is Huntington's disease a tauopathy?

Maud Gratuze et al.

BRAIN (2016)

Review Neurosciences

Tau and tauopathies

Thomas Arendt et al.

BRAIN RESEARCH BULLETIN (2016)

Review Cell Biology

Stability Properties of Neuronal Microtubules

Peter W. Baas et al.

CYTOSKELETON (2016)

Article Biochemistry & Molecular Biology

Mutant huntingtin alters Tau phosphorylation and subcellular distribution

David Blum et al.

HUMAN MOLECULAR GENETICS (2015)

Article Biochemistry & Molecular Biology

Tau hyperphosphorylation and deregulation of calcineurin in mouse models of Huntington's disease

Maud Gratuze et al.

HUMAN MOLECULAR GENETICS (2015)

Article Biochemistry & Molecular Biology

Tau exon 2 responsive elements deregulated in myotonic dystrophy type I are proximal to exon 2 and synergistically regulated by MBNL1 and MBNL2

C. Carpentier et al.

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2014)

Article Biochemistry & Molecular Biology

Huntington's disease is a four-repeat tauopathy with tau nuclear rods

Marta Fernandez-Nogales et al.

NATURE MEDICINE (2014)

Review Neurosciences

Regulation of alternative splicing of tau exon 10

Wei Qian et al.

NEUROSCIENCE BULLETIN (2014)

Article Biochemistry & Molecular Biology

MAPT expression and splicing is differentially regulated by brain region: relation to genotype and implication for tauopathies

Daniah Trabzuni et al.

HUMAN MOLECULAR GENETICS (2012)

Article Biochemistry & Molecular Biology

MicroRNA-132 loss is associated with tau exon 10 inclusion in progressive supranuclear palsy

Pascal Y. Smith et al.

HUMAN MOLECULAR GENETICS (2011)

Review Clinical Neurology

Huntington's disease: from molecular pathogenesis to clinical treatment

Christopher A. Ross et al.

LANCET NEUROLOGY (2011)

Article Biochemistry & Molecular Biology

Dendritic Function of Tau Mediates Amyloid-β Toxicity in Alzheimer's Disease Mouse Models

Lars M. Ittner et al.

Review Biochemistry & Molecular Biology

Tau gene alternative splicing: expression patterns, regulation and modulation of function in normal brain and neurodegenerative diseases

A Andreadis

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2005)